Current understanding of hepatic and intestinal OATP-mediated drug–drug interactions
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current understanding of hepatic and intestinal OATP-mediated drug–drug interactions
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume 4, Issue 6, Pages 729-742
Publisher
Informa UK Limited
Online
2011-10-31
DOI
10.1586/ecp.11.58
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of Organic Anion-Transporting Polypeptides for Cellular Mesalazine (5-Aminosalicylic Acid) Uptake
- (2011) J. Konig et al. DRUG METABOLISM AND DISPOSITION
- Reevaluation of the Microsomal Metabolism of Montelukast: Major Contribution by CYP2C8 at Clinically Relevant Concentrations
- (2011) A. M. Filppula et al. DRUG METABOLISM AND DISPOSITION
- Effect of the CYP2C8 Genotype on the Pharmacokinetics and Pharmacodynamics of Repaglinide
- (2011) D. Tomalik-Scharte et al. DRUG METABOLISM AND DISPOSITION
- Clinical Importance of OATP1B1 and OATP1B3 in DrugDrug Interactions
- (2011) Yoshihisa Shitara Drug Metabolism and Pharmacokinetics
- Differential modulation of the expression of important drug metabolising enzymes and transporters by endothelin-1 receptor antagonists ambrisentan and bosentan in vitro
- (2011) Johanna Weiss et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Evaluation of possible drug-drug interaction between gadoxetic acid and erythromycin as an inhibitor of organic anion transporting peptides (OATP)
- (2011) Alexander Huppertz et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- The role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells
- (2010) Anja Zahno et al. BIOCHEMICAL PHARMACOLOGY
- Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren
- (2010) Tuija Tapaninen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Gemfibrozil Markedly Increases the Plasma Concentrations of Montelukast: A Previously Unrecognized Role for CYP2C8 in the Metabolism of Montelukast
- (2010) T Karonen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Potential for Pharmacokinetic Interactions Between Ambrisentan and Cyclosporine
- (2010) R Spence et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Rifampin's Acute Inhibitory and Chronic Inductive Drug Interactions: Experimental and Model-Based Approaches to Drug–Drug Interaction Trial Design
- (2010) M L Reitman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Hepatic Uptake of the Magnetic Resonance Imaging Contrast Agent Gd-EOB-DTPA: Role of Human Organic Anion Transporters
- (2010) M. Leonhardt et al. DRUG METABOLISM AND DISPOSITION
- Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren
- (2010) Tuija Tapaninen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of Gemfibrozil and Fenofibrate on the Pharmacokinetics of Atorvastatin
- (2010) Lloyd R. Whitfield et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Hepatocellular Carcinoma: Hepatocyte-selective Enhancement at Gadoxetic Acid–enhanced MR Imaging—Correlation with Expression of Sinusoidal and Canalicular Transporters and Bile Accumulation
- (2010) Takahiro Tsuboyama et al. RADIOLOGY
- The effect of acute administration of rifampicin and imatinib on the enterohepatic transport of rosuvastatinin vivo
- (2010) E. Bergman et al. XENOBIOTICA
- Contribution of organic anion transporting polypeptide OATP2B1 to amiodarone accumulation in lung epithelial cells
- (2009) Satoru Seki et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- No significant effect ofABCB1haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin
- (2009) Jenni E. Keskitalo et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Human Skeletal Muscle Drug Transporters Determine Local Exposure and Toxicity of Statins
- (2009) Michael J. Knauer et al. CIRCULATION RESEARCH
- Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism
- (2009) Yi-Jing He et al. CLINICA CHIMICA ACTA
- Drug Uptake Systems in Liver and Kidney: A Historic Perspective
- (2009) B Hagenbuch CLINICAL PHARMACOLOGY & THERAPEUTICS
- CYP2C8 Activity Recovers within 96 Hours after Gemfibrozil Dosing: Estimation of CYP2C8 Half-Life Using Repaglinide as an in Vivo Probe
- (2009) J. T. Backman et al. DRUG METABOLISM AND DISPOSITION
- Human Platelets Express Organic Anion-Transporting Peptide 2B1, an Uptake Transporter for Atorvastatin
- (2009) J. Niessen et al. DRUG METABOLISM AND DISPOSITION
- Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs
- (2009) Ichiro Ieiri et al. Expert Opinion on Drug Metabolism & Toxicology
- Effect of Ketoconazole on the Pharmacokinetic Profile of Ambrisentan
- (2009) Duncan B. Richards et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Hepatic OATP1B Transporters and Nuclear Receptors PXR and CAR: Interplay, Regulation of Drug Disposition Genes, and Single Nucleotide Polymorphisms
- (2009) Henriette E. Meyer zu Schwabedissen et al. MOLECULAR PHARMACEUTICS
- Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response
- (2009) Edward B. Mougey et al. Pharmacogenetics and Genomics
- Overexpression of OATP1B3 Confers Apoptotic Resistance in Colon Cancer
- (2008) W. Lee et al. CANCER RESEARCH
- Effect of SLCO1B3 Haplotype on Testosterone Transport and Clinical Outcome in Caucasian Patients with Androgen-Independent Prostatic Cancer
- (2008) A. Hamada et al. CLINICAL CANCER RESEARCH
- Clinical Pharmacokinetics and Pharmacodynamics of Aliskiren
- (2008) Sujata Vaidyanathan et al. CLINICAL PHARMACOKINETICS
- Effects of Gemfibrozil and Atorvastatin on the Pharmacokinetics of Repaglinide in Relation to SLCO1B1 Polymorphism
- (2008) A Kalliokoski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Elucidating Rifampin's Inducing and Inhibiting Effects on Glyburide Pharmacokinetics and Blood Glucose in Healthy Volunteers: Unmasking the Differential Effects of Enzyme Induction and Transporter Inhibition for a Drug and Its Primary Metabolite
- (2008) HX Zheng et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetics of rosuvastatin when coadministered with rifampicin in healthy males: A randomized, single-blind, placebo-controlled, crossover study
- (2008) Wei Zhang et al. CLINICAL THERAPEUTICS
- Interaction of Oral Antidiabetic Drugs With Hepatic Uptake Transporters: Focus on Organic Anion Transporting Polypeptides and Organic Cation Transporter 1
- (2008) I. Bachmakov et al. DIABETES
- Methotrexate Pharmacokinetics in Transgenic Mice with Liver-Specific Expression of Human Organic Anion-Transporting Polypeptide 1B1 (SLCO1B1)
- (2008) E. van de Steeg et al. DRUG METABOLISM AND DISPOSITION
- The solute carrier (SLC) complement of the human genome: Phylogenetic classification reveals four major families
- (2008) Robert Fredriksson et al. FEBS LETTERS
- Different Effects ofSLCO1B1Polymorphism on the Pharmacokinetics and Pharmacodynamics of Repaglinide and Nateglinide
- (2008) Annikka Kalliokoski et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetics of the Oral Direct Renin Inhibitor Aliskiren in Combination With Digoxin, Atorvastatin, and Ketoconazole in Healthy Subjects: The Role of P-Glycoprotein in the Disposition of Aliskiren
- (2008) Sujata Vaidyanathan et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Targeted Disruption of Murine Organic Anion-Transporting Polypeptide 1b2 (oatp1b2/Slco1b2) Significantly Alters Disposition of Prototypical Drug Substrates Pravastatin and Rifampin
- (2008) H. Zaher et al. MOLECULAR PHARMACOLOGY
- No significant effect ofSLCO1B1polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone
- (2007) Annikka Kalliokoski et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started